Retatrutide Dosage Guide
85/100 confidenceComplete guide to Retatrutide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
500 mcg - 1 mg
Route
subq
Frequency
Weekly
Cycle Length
4 weeks
Reconstitution
Vial Size
20 mg
BAC Water
2 ml
Concentration
10,000 mcg/ml
Detailed Dosage Information
Clinical trials used doses from 1mg to 12mg weekly. Optimal dosing still being determined in ongoing Phase 3 trials.
Administration Method
Subcutaneous injection once weekly. Currently only available through clinical trials - not yet FDA approved.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 10,000 mcg/ml
Volume to inject: 0.05 ml
Syringe units (U-100): 5.0 units
Pre-filled with Retatrutide defaults. Adjust values as needed.
Research Backing
Phase 2/3 REDEFINE trials (NEJM/Lancet 2023–2026 updates) showing 20–24%+ weight loss; robust safety database.
Side Effects to Monitor
Similar GI effects to other incretin-based therapies: nausea, diarrhea, vomiting, constipation. Dose-dependent severity.
Safety Considerations & Risks
Still investigational - full safety profile being established. Expected similar warnings to GLP-1 class regarding thyroid, pancreatitis, and gallbladder.